Cancer Care, Expertly Navigated
We connect patients with the world's leading oncology programs, second opinions, clinical trials, and treatment travel, coordinated by a team that has done this for thousands of families.
Hi, I see you found us. If you're scared, I was too. A year ago I was Stage IV and had no options at home. CancerFax found me a trial 4,000 miles away. You're not alone in this.
How Can We Help You Today?
Choose where you are in your cancer journey and we'll guide you to the right resources and next steps.
Explore Advanced Treatments
CAR-T, TIL therapy, gene therapy, immunotherapy and more β understand what's available for your diagnosis.
Find Cancer-Specific Options
Search treatment and trial options tailored to your specific cancer type, stage, and molecular profile.
Get a Second Opinion
Access specialist review of your diagnosis, imaging, pathology, and current treatment plan from expert oncologists.
Search Clinical Trials
Explore investigational therapies and clinical trial opportunities that may be appropriate for your condition.
Compare Hospitals & Doctors
Understand your options across leading cancer centres, specialist expertise, and international treatment destinations.
Plan Treatment Abroad
End-to-end support for international care: visa guidance, medical coordination, travel assistance, and more.
End-to-End Cancer Navigation
"Three pillars that move patients from uncertainty to clarity and from clarity to action."
Treatment Access Guidance
We help patients understand which advanced therapies β CAR-T, TIL, gene therapy, immunotherapy, targeted drugs, proton therapy β are relevant to their diagnosis, stage, and molecular markers. We translate complex clinical information into clear, actionable guidance.
Clinical Navigation
CancerFax guides patients through the complexity of global oncology β matching them to appropriate specialists, relevant trials, and the right institutions based on their specific needs. We help patients ask better questions and make more informed decisions.
End-to-End Coordination
From medical document preparation and hospital communication to visa support, logistics planning, and care continuity β CancerFax coordinates the full journey so patients and families can focus entirely on what matters most.
The Latest in Advanced Cancer Treatment
From CAR-T and TIL therapy to gene therapy and proton treatment, we help patients access the newest cancer therapies available at leading centers in China, India, and beyond. Our team carefully reviews every option and matches it to your specific case.
Featured Treatment Areas
We cover the full landscape of advanced oncology, from cell therapies to precision radiation and clinical trials.
CAR-T Cell Therapy
CAR-T cell therapy is an adoptive cell therapy that genetically engineers a patient's own T-cells to express a chimeric antigen receptor (CAR) β a synthetic protein that directs T-cells to recognize and destroy cancer cells. First conceptualized by Zelig Eshhar in the late 1980s and brought to clinical success by Carl June's group at Penn in 2010β2012, the first FDA approval (Kymriah for pediatric B-ALL) followed in August 2017.
Learn more βTreatmentTumor Therapeutic Vaccines
Tumor therapeutic vaccines are cancer immunotherapy treatments given to patients who already have cancer, not to prevent it. They stimulate the immune system to recognize tumor-specific antigens, mount a targeted T-cell response, and destroy cancer cells throughout the body.
Learn more βTreatmentCAR NK Cell Therapy
To grasp the reason behind the significant leap of CAR NK cell therapy over CAR-T cell therapy, it is first necessary to understand the nature of natural killer cells and their fundamental distinction from the T-cells that are used in CAR-T cell therapy. The distinction between the two types of cells is clinically significant in terms of safety, ease of access, and the types of cancer targeted.
Learn more βTreatmentBone Marrow Transplant
In cancer treatment, bone marrow transplant refers to hematopoietic stem cell transplantation (HSCT), a procedure where the patient's bone marrow is destroyed with high-dose chemotherapy and radiation, then rebuilt with healthy stem cells from a donor or the patient's own stored cells.
Learn more βTreatmentCIK Therapy
Cytokine-induced killer (CIK) cell therapy is an adoptive immunotherapy in which a patient's own peripheral blood cells are collected, activated ex vivo over 2β3 weeks using IFN-gamma, anti-CD3 antibody, IL-1, and IL-2, and reinfused to kill cancer cells. First described at the German Cancer Research Centre (DKFZ) in the early 1990s, it has since been developed into the world's largest non-CAR adoptive cell therapy programme β overwhelmingly in China.
Learn more βTreatmentGendicine Gene Therapy
Gendicine (recombinant human adenovirus-p53) is a gene therapy medicine produced by Shenzhen SiBiono GeneTech, approved by China's SFDA in 2003 for head and neck squamous cell carcinoma β making it the world's first commercially approved cancer gene therapy. It is relevant for solid tumour patients for three reasons: it has a validated 20-year clinical history in China, it targets the most universally disrupted pathway in solid cancers (p53/TP53), and it is most used as an add-on to radiation or chemotherapy β not as a replacement.
Learn more βTreatmentBNCT
BNCT exploits a fundamental nuclear reaction to destroy cancer cells with extraordinary selectivity β introducing a biological layer of targeting that conventional radiotherapy cannot achieve.
Learn more βMRNA CANCER VACCINEmRNA Vaccines in Cancer Treatment
Most patients first heard of mRNA vaccines during COVID-19. The same platform is now being directed at cancer, with a fundamentally different goal: not prevention, but treatment of existing disease.
Learn more βStories That Stay With Us
From second opinions to cross-border treatment coordination, these are real people who chose to explore further. Their courage inspires everything we do.
VerifiedββI came with fear and uncertainty but found hope, expert care, and genuine compassion here. The team supported me medically and emotionally, giving me confidence to move forward.ββ
VerifiedββWhen hope felt distant after relapse, the team here gave me strength, clarity, and a second chance. Their care, precision treatment, and constant support changed my future.ββ
Verified
Verified
Verified
VerifiedAnnouncements & updates
New partnerships, treatments we now cover, fresh guides and upcoming events β the latest milestones in widening access to care.
Why Patients Choose CancerFax
"We don't book hospitals. We walk beside families navigating the hardest decisions of their lives, with compassion, care, and commitment that doesn't waver."
Advanced Treatment Focus
Specialized expertise in therapies that are often inaccessible locally, cell therapy, gene therapy, precision oncology, and clinical trials.
Cross-Border Coordination
Comprehensive support across international treatment destinations, case review, admissions, hospital communication, and logistics.
Hospital & Doctor Navigation
Guidance on the right institutions, specialist matching based on diagnosis, and center selection tailored to clinical complexity.
Clinical Trial Awareness
Support in identifying and exploring clinical trial options when appropriate, including mutation-specific and late-line investigational pathways.
Compassionate Support
Human guidance for patients and families navigating difficult decisions, with emphasis on clarity, honesty, and realistic, informed hope.
Independent Second Opinions
Access trusted second opinions from global cancer specialists, ensuring every diagnosis, treatment plan, and decision is reviewed with expert clarity.
Trusted by Patients & Professionals
CancerFax works with leading cancer centres, specialists, and institutions across multiple countries.
CancerFax is a patient guidance and care coordination platform. We do not provide direct medical treatment. All treatment decisions are made by licensed medical professionals and partner hospitals. Information provided is for guidance and educational purposes only, and does not constitute medical advice.
How It Works
A clear, structured, and compassionate four-step process designed to bring order to a difficult moment.
Share Your Reports
Upload your pathology reports, imaging results, treatment history, and any relevant clinical documents securely through our platform.
Our Team Reviews Your Case
CancerFax specialists conduct a thorough clinical review of your diagnosis, disease stage, biomarkers, and treatment history.
Identify Treatment Pathways
We explore suitable advanced therapies, clinical trial opportunities, and international treatment options relevant to your case.
Coordinate Next Steps
We help arrange specialist consultations, hospital admissions, additional diagnostics, logistics, and ongoing care coordination.
Featured Clinical Trials
Investigational therapies currently recruiting patients. Share your reports with us and we will help assess your eligibility.
CD19-BCMA Dual-Target CAR-T Cell Therapy for Refractory SLE Nephritis, Systemic Sclerosis, and SjΓΆgren Syndrome with Pulmonary Artery Hypertension (Phase 1/2)
Check Eligibility βA Phase I Study of the In Vivo CAR-T Platform for Treating Advanced Malignant Tumors Based on Target Screening (V001 Injection)
Check Eligibility βCytokine-induced Killer (CIK) Cell Therapy and Its Impact on Early Functional Exhaustion of Chimeric Antigen Receptor-T (CAR-T) Cells in Relapsed or Refractory Acute B-Lymphoblastic Leukemia: A Prospective Study
Check Eligibility βA Phase II Clinical Study of SHR-A1904 Monotherapy in Second-Line or Later Treatment of Advanced Neuroendocrine Carcinoma
Check Eligibility βEligibility for clinical trials depends on your specific diagnosis, prior treatment history, biomarker profile, and other clinical factors. Share your reports with our team and we will assess which trials you may qualify for.
Explore Options by Cancer Type
Select your diagnosis to explore advanced treatment options, relevant clinical trials, and guidance specific to that cancer type.
Lung Cancer
NSCLC, SCLC, EGFR, ALK, ROS1, KRAS G12C, MET, PD-L1
Breast Cancer
ER+/PR+, HER2+, TNBC, Lobular, Ductal, Inflammatory
Colorectal Cancer (Colon & Rectal)
Left-sided, Right-sided, MSI-H/dMMR, BRAF V600E, HER2-amplified, RAS-mutant
Prostate Cancer
Acinar adenocarcinoma, Ductal adenocarcinoma, Small cell carcinoma, BRCA2-associated, AR-V7 splice variant
Stomach Cancer
Intestinal-type, Diffuse-type (Lauren classification), HER2-positive, MSI-H/dMMR, EBV-positive, Signet ring cell, Linitis plastica, Gastroesophageal junction adenocarcinoma
Liver Cancer
HCC, Intrahepatic cholangiocarcinoma, Fibrolamellar, Hepatoblastoma, Angiosarcoma
Pancreatic Cancer
Ductal adenocarcinoma, Acinar cell carcinoma, Neuroendocrine tumor/carcinoma (NET/NEC), KRAS-mutant
Cervical Cancer
Squamous cell, Adenocarcinoma, Adenosquamous
Leukemia
ALL, AML, CLL, CML, APL, CMML, Hairy Cell Leukemia, LGL Leukemia
Multiple Myeloma
IgG, IgA, Light Chain Myeloma; cytogenetic subtypes including t(4;14), del(17p), 1q gain
Oral Cancer
Squamous cell carcinoma, adenocarcinoma, mucoepidermoid carcinoma, HPV-positive oropharyngeal cancer, HPV-negative oral cavity cancer
Thyroid Cancer
Papillary, Follicular, Medullary, Anaplastic, HΓΌrthle cell
Patients Who Found a Way Forward
Real experiences from patients who explored advanced treatment options with CancerFax's guidance and coordination, in their words.
CAR T Cell Therapy for Leukemia at Lu Daopei Hospital: A Syrian Patientβs Journey.
How CancerFax connects multiple myeloma patients to advanced CAR-T cell therapy at top hospitals in China, including Jiahui International.
Inside China's #1 oncology centre, a tour of the National Cancer Center in Beijing, a leading destination for international cancer patients.
Trusted Oncology Specialists
CancerFax works with an internationally credentialed panel of oncologists, hematologists, and precision medicine specialists, helping patients access the right expertise for their specific cancer type and stage.
Our expert panel assists with case review, second opinions, and treatment pathway guidance. Consultations are coordinated by the CancerFax team and do not constitute a formal medical consultation.
Partner Hospitals & Cancer Centres
CancerFax works with leading oncology institutions globally, connecting patients to expertise, advanced treatments, and specialized care programs.
Cancer Hospital, Chinese Academy of Medical Sciences
China's National Cancer Center, founded 1958. The country's flagship oncology hospital with 1,500 beds and 1M+ outpatients annually. Via CancerFax.
Learn More
The University of Texas MD Anderson Cancer Center
World's #1 cancer hospital by US News for over a decade, with the world's largest cancer clinical trials programme in Houston, Texas. Via CancerFax.
Learn More
Apollo Cancer Institute, Chennai
High-volume cancer centre in Chennai offering surgical oncology, bone marrow transplant, advanced radiation and immunotherapy access via CancerFax.
Learn More
Beijing GoBroad Boren Hospital
Hematology-specialty hospital in Beijing with 30 CAR-T targets and world-leading sequential CAR-T outcomes for refractory leukaemia. Via CancerFax.
Learn More
Beijing Arion Cancer Center
Beijing Arion Cancer Center (ηΎδΈη±η) is Beijing's premier private Grade III cancer hospital, built around real-time full-course MDT care and a UPMC strategic partnership. Access advanced oncology via CancerFax.
Learn More
Shenzhen Children's Hospital
Guangdong's only Grade 3A pediatric hospital, ranked top in pediatric hematology and oncology. 2,800+ beds across Futian and Longhua campuses. Via CancerFax.
Learn MoreResources for Informed Decisions
Guides, updates, and practical information for patients, families, and caregivers at every stage.
Treatment Guides
In-depth, patient-friendly guides to advanced cancer therapies, eligibility, mechanisms, and expected outcomes.
Explore GuidesTrial Updates
Regular updates on active and recruiting clinical trials across key cancer types, geographies, and therapy classes.
View UpdatesPatient Explainers
Clear, jargon-free explanations of diagnoses, biomarkers, treatment modalities, and what to ask your oncologist.
Read ExplainersDestination Comparisons
Detailed comparisons of international treatment destinations, costs, access, specialization, and coordination considerations.
Compare DestinationsFrequently Asked Questions
"Have a question that isn't covered here? Speak with our patient navigation team; every case is reviewed individually."
Not Sure What's Next?
Share your reports, and our team will help you explore possible next steps, treatment pathways, and care coordination options compassionately, clearly, and without pressure.